You are here

tirzepatide

Patients scramble as cheaper obesity drug alternatives disappear

NPR

Thu, 03/20/25 - 11:15 am

compounding pharmacies

Off-label use of semaglutide and tirzepatide shows promise in type 1 diabetes

Clinical Trials Arena

Mon, 03/10/25 - 11:13 pm

type 1 diabetes

BioAge shares tumble after decision to halt obesity drug study

BioPharma Dive

Sun, 12/8/24 - 09:46 pm

clinical trials

Eli Lilly’s weight-loss drug helps nearly 99% of patients remain diabetes-free

Pharma Live

Thu, 11/14/24 - 11:21 am

FDA to reconsider decision barring compounded versions of Lilly weight loss drug

Reuters

Sun, 10/13/24 - 11:33 am

compounded drugs

Lilly’s tirzepatide cuts diabetes risk, study data show

BioPharma Dive

Tue, 08/20/24 - 11:54 am

type 2 diabetes

clinical trials

Eli Lilly's weight loss drug tirzepatide gets approval in China

Reuters

Fri, 07/19/24 - 11:45 am

Boehringer, Lilly face off in MASH at EASL

Pharmaphorum

Mon, 06/10/24 - 11:14 am

Boehringer Ingelheim

Lilly’s Tirzepatide Shows Positive Phase II NASH Data, Tees Up Potential Expansion

BioSpace

Wed, 06/5/24 - 11:08 am

clinical trials

Lilly wins NICE endorsement for tirzepatide in obesity—with a catch

Fierce Pharma

Tue, 06/4/24 - 11:38 am

type 2 diabetes

Lilly Suffers Legal Loss in Tirzepatide Case Against Compounding Pharmacy

BioSpace

Fri, 04/12/24 - 11:13 am

compounding pharmacies

Eli Lilly mounts clinical and commercial case for tirzepatide as Mounjaro, Zepbound chalk up major gains

Fierce Pharma

Tue, 02/6/24 - 09:33 am

Eli Lilly Was Hoping for 5 Big Drug Launches This Year. Here's How It Has Done Thus Far.

Motley Fool

Fri, 11/10/23 - 12:19 pm

How Eli Lilly’s obesity drug Zepbound is poised to reshape pharma markets

Medical Marketing and Media

Thu, 11/9/23 - 11:41 pm

Lilly to help BioAge test muscle regeneration therapy in combo with weight loss drug tirzepatide

Fierce Biotech

Thu, 10/26/23 - 10:46 pm

muscle regeneration

Lilly’s Tirzepatide Shows Strong Weight Loss Efficacy in Phase III Study

BioSpace

Mon, 10/16/23 - 10:17 am

clinical trials

Quitting Lilly's obesity drug tirzepatide may be difficult for many patients, exec says

Fierce Pharma

Thu, 04/27/23 - 10:48 pm

Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo Nordisk's Wegovy

Fierce Pharma

Thu, 10/6/22 - 10:59 am

Eli Lilly touts early demand for high-stakes diabetes launch Mounjaro: analysts

Fierce Pharma

Thu, 09/15/22 - 10:34 am

Lilly's highly anticipated diabetes drug Mounjaro wins FDA blessing

Fierce Pharma

Sun, 05/15/22 - 11:07 pm

type 2 diabetes

Pages